Close

Monoclonal Porcine (Pig) Antibody Discovery Introduction

Overview Application Scenarios Platforms Workflow Our Core Advantages FAQ

Brief Introduction to Porcine Monoclonal Antibodies

Pigs are not only one of the most important livestock animals globally, but also occupy a unique position in biomedical research. Their anatomical structure, physiological metabolism, and immune system closely resemble those of humans, making them an ideal animal model for xenotransplantation, vaccine development, and disease modeling.

Compared with murine or rabbit-derived antibodies, porcine monoclonal antibodies display lower immunogenicity and better therapeutic efficacy when administered in pigs. At present, major swine diseases including Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Classical Swine Fever Virus (CSFV), and Porcine Epidemic Diarrhea Virus (PEDV) inflict tens of billions of US dollars in economic losses on the global pig industry each year. Market demand for such antibodies is rising rapidly in fields covering veterinary biologics, swine disease diagnostic reagents, vaccine quality testing and xenotransplantation research. Accordingly, the development of highly specific, low-immunogenicity porcine monoclonal antibodies holds irreplaceable strategic value for realizing precise prevention and control of swine diseases, safeguarding food safety, and advancing research on zoonotic diseases.

Fig.1 Porcine. (Creative Biolabs AI)

Learn how porcine mAbs can advance your R&D project → Our experts are here to help

Porcine mAbs Empowering Multi-Domain Research and Industry

From diagnostic reagent core materials to therapeutic antibody drug development, porcine monoclonal antibodies have broad application prospects in veterinary biologics.

Fig.2 Pig. (Creative Biolabs AI)

Swine Disease Diagnostics

Core raw materials for ELISA, immunofluorescence, WB kits.

Fig.3 Drugs. (Creative Biolabs AI)

Therapeutic Antibody Drugs

PRRSV neutralizing antibody and other veterinary biologic R&D.

Fig.4 Vaccine. (Creative Biolabs AI)

Vaccine Quality Control

Vaccine potency assessment and reference standard development.

Fig.5 Research. (Creative Biolabs AI)

Basic Research Tools

Porcine immunology mechanism studies, signaling pathway research.

What is your application scenario? Tell us and get a tailored solution

Core Technology Platforms

Creative Biolab integrate single B cell screening, phage display, and hybridoma platforms to provide the optimal porcine monoclonal antibody discovery strategy based on target characteristics and project goals.

Fig.6 Phage. (Creative Biolabs AI)

Phage Display Technology

Fuse antibody gene fragments with phage coat protein to display antibody libraries on phage surfaces; perform affinity screening through antigen incubation. Enables construction of high-diversity antibody libraries, bypassing traditional hybridoma immunization limitations, suitable for difficult-to-immunize targets.

  • High diversity
  • No immunization limit
  • Affinity maturation

Fig.7 Antibody. (Creative Biolabs AI)

Single B Cell Screening

Isolate antigen-specific single B lymphocytes from immunized or convalescent pig peripheral blood; obtain antibody gene sequences via sequencing; express native fully porcine monoclonal antibodies in mammalian cells.

  • High-throughput
  • Fully porcine
  • Native pairing
  • Rapid

Fig.8 Cells. (Creative Biolabs AI)

Hybridoma Technology

Fuse splenocytes from immunized animals with myeloma cells to generate hybridoma cell lines stably secreting specific antibodies. A classic, robust technology yielding high specificity and high affinity antibodies, ideal for routine porcine mAb preparation needs.

  • Classic & Mature
  • High specificity
  • Stable secretion

Unsure which technology route fits your project? We'll help you decide. Get a Customized Plan

One-Stop Service Process, Transparent & Efficient Delivery

Creative Biolabs delivers end-to-end project management covering initial consultation through final product delivery, with rigorous quality assurance and full traceability of all experimental data.

Fig.9 Number One. (Creative Biolabs AI)Project Consultation

Fig.10 Number Two. (Creative Biolabs AI)Study Design

Fig.11 Number Three. (Creative Biolabs AI)Antigen Prep / Animal Immunization

Fig.12 Number Four. (Creative Biolabs AI)Antibody Screening (Three Platforms)

Fig.13 Number Five. (Creative Biolabs AI)Antibody Expression & Purification

Fig.14 Number Six. (Creative Biolabs AI)Functional Validation

Fig.15 Delivery. (Creative Biolabs AI)Delivery

Start your porcine mAb discovery project

How Creative Biolabs Empowers Your Research?

With years of deep experience in antibody discovery, Creative Biolabs have become a trusted partner for numerous research institutions and biopharma companies through our technical expertise and extensive project track record.

Multi-Species Experience

Successful antibody discovery across porcine, murine, rabbit, alpaca, human, and more.

Three Integrated Platforms

Flexible combination of single B cell, phage display, and hybridoma to match any project.

One-Stop Full Service

From antigen design to functional validation, no need to coordinate multiple vendors.

Fast Delivery & Rigorous QC

Standardized SOPs and strict quality systems ensure complete data traceability.

Professional Team

A PhD-driven technical team with ample project experience to offer profound technical assistance.

Trusted Partner

Serving top universities, biotech firms, and research institutes with outstanding reputation.

Choose a professional partner → Let us safeguard your project

Your Questions Answered

Common questions about porcine monoclonal antibody discovery services. Feel free to reach out for more details.

  1. What are the main differences between porcine and murine monoclonal antibodies?

    Porcine mAbs exhibit significantly lower immunogenicity in pigs compared to murine antibodies, reducing anti-drug antibody (ADA) responses and prolonging in vivo half-life for improved therapeutic efficacy. Additionally, the Fc region of porcine antibodies is more compatible with the pig immune system, offering natural advantages in veterinary biologic applications.

  2. How do I choose among single B cell screening, phage display, and hybridoma?

    Selection is determined by target characteristics, intended antibody use and project timeline:

    • Single B cell screening: Best for rapidly obtaining native paired fully porcine antibodies, preserving full immune repertoire diversity; recommended for therapeutic antibody development.
    • Phage display: Suitable for difficult-to-immunize targets or when high-affinity antibodies are needed; bypasses immunization constraints.
    • Hybridoma: Classic mature technology, ideal for routine mAb preparation with relatively controllable costs.

    Our technical team will recommend the optimal route based on your specific needs.

  3. Which pig strains can be customized?

    Creative Biolabs support antibody discovery from multiple pig breeds. For special strain requirements, please communicate in advance and we will strive to accommodate.

  4. What downstream applications can the delivered antibodies be used for?

    Delivered porcine mAbs can be widely applied in: ELISA kit development, immunofluorescence (IF), Western Blot, immunohistochemistry (IHC), neutralization assays, vaccine quality control reference standards, and therapeutic antibody candidate research. We can customize antibody specifications and purification schemes according to your downstream needs.

More questions? Our online support is ready to help


All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us